Stay updated on Dupilumab in Pediatric Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Asthma Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Asthma Clinical Trial page
- Check3 days agoChange DetectedThe record displays details of the completed dupilumab asthma study, including its design, eligibility criteria, outcome measures, participating locations, publications, and study documents.SummaryDifference100%

- Check10 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide banner announces a transition in NIH terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check24 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study record content with an error screen; the original detailed content and links have been removed and replaced by the error header and minimal footer.SummaryDifference20%

Stay in the know with updates to Dupilumab in Pediatric Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Asthma Clinical Trial page.